CK2 in the spotlight: decoding its role in hematological malignancies and therapeutic applications
Abstract Protein kinase CK2 is known to have potent biological effects, and its high expression is closely associated with malignant phenotypes of tumors, especially hematological malignancies. Targeting protein kinase CK2 is a promising therapeutic direction in hematological malignancies, as it pro...
Saved in:
| Main Authors: | Zhaoyi Cai, Qiang Luo, Yuqun Zhang, Rui Meng, Ming Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02797-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global, regional, and national economic burden of hematologic malignancies (1990–2021) with projections to 2050
by: Zhexian Li, et al.
Published: (2025-06-01) -
Prevalence of hematological malignancies in Africa: A systematic review and meta-analysis
by: Zewudu Mulatie, et al.
Published: (2025-03-01) -
Trend analysis of hematological tumors in adolescents and young adults from 1990 to 2019 and predictive trends from 2020 to 2044: A Global Burden of Disease study
by: Linlin Huang, et al.
Published: (2024-09-01) -
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
by: Namrata S. Chandhok, et al.
Published: (2025-08-01) -
Therapeutic Benefits of Lenalidomide in Hematological Malignancies
by: Mohammed Shafi Abdulsalam, et al.
Published: (2019-04-01)